AMERICAN SHARED HOSPITAL SERVICES Costs and Expenses
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Costs and Expenses of $2.93 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2021-05-13
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for the quarter ending 2021-03-31 was $2.93M, a 7.69% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for the quarter ending 2020-12-31 was $3.58M, a 7.06% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for the quarter ending 2020-09-30 was $3.53M, a 1.26% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for the quarter ending 2020-06-30 was $3.08M, a 11.07% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for fiscal 2020 was $13.37M, a 2.29% decline from fiscal 2019.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for fiscal 2019 was $13.69M, a 11.92% increase from fiscal 2018.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for fiscal 2018 was $12.23M, a 12.26% increase from fiscal 2017.
- AMERICAN SHARED HOSPITAL SERVICES costs and expenses for fiscal 2017 was $10.89M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2021-03-31 | $2.93M 10-Q · filed 2021-05-13 | $6.51M derived: sum of 2 quarters · filed 2021-05-13 | $10.04M derived: sum of 3 quarters · filed 2021-05-13 | $13.13M derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | $3.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-06 | $7.11M derived: sum of 2 quarters · filed 2021-04-06 | $10.20M derived: sum of 3 quarters · filed 2021-04-06 | $13.37M 10-K · filed 2021-04-06 |
| 2020-09-30 | $3.53M 10-Q · filed 2020-11-13 | $6.62M derived: sum of 2 quarters · filed 2020-11-13 | $9.79M 10-Q · filed 2020-11-13 | $13.13M derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-06-30 | $3.08M 10-Q · filed 2020-08-14 | $6.26M 10-Q · filed 2020-08-14 | $9.60M derived: sum of 3 quarters · filed 2021-05-13 | $13.09M derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-03-31 | $3.17M 10-Q · filed 2021-05-13 | $6.52M derived: sum of 2 quarters · filed 2021-05-13 | $10.01M derived: sum of 3 quarters · filed 2021-05-13 | $13.47M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-06 | $6.83M derived: sum of 2 quarters · filed 2021-04-06 | $10.30M derived: sum of 3 quarters · filed 2021-04-06 | $13.69M 10-K · filed 2021-04-06 |
| 2019-09-30 | $3.49M 10-Q · filed 2020-11-13 | $6.96M derived: sum of 2 quarters · filed 2020-11-13 | $10.34M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $3.47M 10-Q · filed 2020-08-14 | $6.85M 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | $3.38M 10-Q/A · filed 2020-06-11 | |||
| 2018-12-31 | $12.23M 10-K · filed 2020-04-03 | |||
| 2017-12-31 | $10.89M 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |